Find a Tender
complete
Official procurement procedure
NP93823b Cell-based Quadrivalent Influenza Vaccine
Influenza vaccines
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"): "NP93823b Cell-based Quadrivalent Influenza Vaccine". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS"). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
1Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 2 active published awards; 2 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published18 May 2023, 11:32 BST | Last source update18 May 2023, 11:32 BST | Recurring procurementNot published |
ClassificationInfluenza vaccines | ||
Delivery area UK | ||
OCIDocds-h6vhtk-03bca6 | ||
What is being bought
This procurement is for the supply of cell-based quadrivalent influenza vaccine for use in the NHS Scotland 2023/24 Seasonal Flu Programme
What changed
From the official release history
- Official notice release published
18 May 2023, 11:32 BST - Buyer information updated
18 May 2023, 11:32 BST - Status changed to complete
5 Apr 2023, 10:10 BST - Official notice release published
5 Apr 2023, 10:10 BST - Buyer information updated
5 Apr 2023, 10:10 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThis procurement is for the supply of cell-based quadrivalent influenza vaccine for use in the NHS Scotland 2023/24 Seasonal Flu Programme.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
18 May 2023, 11:32 BST - Award active
Not published · Not published - Contract active
Signed 5 May 2023, 00:00 BST · £10,824,000
Commercial outcome and competition
Awards Seqirus UK Limited Not published · Not published · active |
Contracts Contract £10,824,000 · signed 5 May 2023, 00:00 BST · active |
Bid statistics bids: 1 (lot 1) electronicBids: 1 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 1 (lot 1) smeBids: 0 (lot 1) |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Contracting authority GB-FTS-83103Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleSeqirus UK Limited are the sole supplier of cell-based quadrivalent influenza vaccine. |